PROFUND ADVISORS LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$59,000
-15.7%
11,333
+8.3%
0.00%
-33.3%
Q1 2021$70,000
+40.0%
10,460
+1.1%
0.00%
+50.0%
Q4 2019$50,000
-77.9%
10,351
-38.0%
0.00%
-85.7%
Q4 2018$226,000
-47.9%
16,688
-14.7%
0.01%
-12.5%
Q3 2018$434,00019,5670.02%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Fosun International Ltd 19,552,001$433,859,00020.80%
BRIDGER MANAGEMENT, LLC 2,642,621$58,640,0003.39%
TPG Group Holdings (SBS) Advisors, Inc. 3,884,600$86,199,0001.10%
HUSSMAN STRATEGIC ADVISORS, INC. 125,000$2,774,0000.80%
HealthCor Management, L.P. 1,036,110$22,991,0000.76%
GW&K Investment Management, LLC 2,049,765$45,484,0000.73%
Bridge City Capital, LLC 50,434$1,119,0000.70%
TCW GROUP INC 2,521,064$55,942,0000.46%
FRONTIER CAPITAL MANAGEMENT CO LLC 2,876,367$63,827,0000.41%
Quadrant Capital Management, LLC 25,002$555,0000.35%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders